2[1]Rosenfeld WE,Sachdeo RC,Faught RE,et al.Long-term experience with TPM as adjunctive therapy and as monotherapy in patients with partial onset seizures:retrospective survey of open-label treatment. Epilepsia,1997,38:34～36.
3[2]Ramsay RE, Sater JD. Antiepileptic drugs in clinical development.New antiepileptic drug development:preclinical and clinical aspects. New York:Elsevier Science Publishers.1993:45～67.
4[3]Elferink AJ, Van ZwietenB BJ. Analysis based on number needed to treat shows differences between drugs studied.BJM,1997,314:603～604.
5[4]Shank RP,Gardocki JF,Vaught JL,et al.Topiramate:preclinical evaluation of a structurally novel anticonvulsant.Epilepsia,1994,35:450～460.
6[5]Gisclon LG,Curtin CR,Kramer LD.The steady-state (SS) pharmacokinetics (PK) of phenytoin and topiramate in epileptic patients on monotherapy and during combination therapy.Epilepsia,1994,35:54～56.
